An AllTrials project

NCT03545191: A reported trial by Idorsia Pharmaceuticals Ltd.

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT03545191
Title Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Polysomnography Study to Assess the Efficacy and Safety of ACT-541468 in Adult and Elderly Subjects With Insomnia Disorder
Results Status Reported
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date June 4, 2018
Completion date Jan. 25, 2020
Required reporting date Jan. 25, 2023, midnight
Actual reporting date Jan. 7, 2022
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None